A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
一项针对复发或难治性霍奇金淋巴瘤患者的 AFM13 联合帕博利珠单抗的 1b 期研究
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2019004701
Bartlett, Nancy L; Herrera, Alex F; Domingo-Domenech, Eva; Mehta, Amitkumar; Forero-Torres, Andres; Garcia-Sanz, Ramon; Armand, Philippe; Devata, Sumana; Izquierdo, Antonia Rodriguez; Lossos, Izidore S; Reeder, Craig; Sher, Taimur; Chen, Robert; Schwarz, Sylvia E; Alland, Leila; Strassz, Andras; Prier, Kim; Choe-Juliak, Cassandra; Ansell, Stephen M